October 3rd, 2023 / News Ubiquigent collaborates with Imperial College London on DUB probe discovery to facilitate preclinical and clinical target engagement studies
June 19th, 2023 / Event Deubiquitylases and Ubl-proteases: from fundamental principles to therapeutic opportunities 2023 (Edinburgh)